002399 海普瑞
已收盘 07-28 15:00:00
资讯
新帖
简况
股东洪泽君增持海普瑞(09989)32.85万股 每股作价约3.99港元
智通财经网 · 07-02
股东洪泽君增持海普瑞(09989)32.85万股 每股作价约3.99港元
海普瑞涨超3%
每日经济新闻 · 06-23
海普瑞涨超3%
港股异动 | 海普瑞(09989)涨超3% 近日旗下依诺肝素钠注射液在肯尼亚获批
智通财经 · 06-23
港股异动 | 海普瑞(09989)涨超3% 近日旗下依诺肝素钠注射液在肯尼亚获批
海普瑞(09989)将于6月18日派发末期股息每10股1.6604港元
智通财经 · 05-26
海普瑞(09989)将于6月18日派发末期股息每10股1.6604港元
海普瑞将于7月22日派发末期股息每10股1.6604港元
新浪港股 · 05-24
海普瑞将于7月22日派发末期股息每10股1.6604港元
海普瑞（002399）披露董事会完成换届选举及聘任高级管理人员、证券事务代表的公告，5月22日股价下跌0.1%
证券之星 · 05-22
海普瑞（002399）披露董事会完成换届选举及聘任高级管理人员、证券事务代表的公告，5月22日股价下跌0.1%
海普瑞(09989)将于7月22日派发末期股息每10股1.6604港元
智通财经 · 05-22
海普瑞(09989)将于7月22日派发末期股息每10股1.6604港元
海普瑞(09989)：王建一获选为职工代表董事
智通财经 · 05-22
海普瑞(09989)：王建一获选为职工代表董事
海普瑞完成换届选举：李锂当选董事长 单宇任总经理
财中社 · 05-22
海普瑞完成换届选举：李锂当选董事长 单宇任总经理
每周股票复盘：海普瑞（002399）Q1净利增19.79%
证券之星 · 05-03
每周股票复盘：海普瑞（002399）Q1净利增19.79%
海普瑞（002399）2026年一季报简析：净利润同比增长19.79%，三费占比上升明显
证券之星 · 05-01
海普瑞（002399）2026年一季报简析：净利润同比增长19.79%，三费占比上升明显
海普瑞（002399）披露2026年第一季度报告，4月29日股价下跌0.09%
证券之星 · 04-29
海普瑞（002399）披露2026年第一季度报告，4月29日股价下跌0.09%
海普瑞(09989)一季度归母净利润1.88亿元 同比增长19.79%
智通财经 · 04-29
海普瑞(09989)一季度归母净利润1.88亿元 同比增长19.79%
海普瑞（002399）披露2025年度业绩说明会安排，4月15日股价上涨0.88%
证券之星 · 04-15
海普瑞（002399）披露2025年度业绩说明会安排，4月15日股价上涨0.88%
股市必读：海普瑞（002399）4月8日董秘有最新回复
证券之星 · 04-09
股市必读：海普瑞（002399）4月8日董秘有最新回复
海普瑞：公司对于Kymab、君圣泰等相关投资均取得了较好的收益表现
证券之星 · 04-03
海普瑞：公司对于Kymab、君圣泰等相关投资均取得了较好的收益表现
商业化与平台能力加速升级 解锁海普瑞长期增长密码
中金财经 · 03-31
商业化与平台能力加速升级 解锁海普瑞长期增长密码
海普瑞(09989)发布年度业绩 股东应占溢利3.49亿元 同比减少45.96%
智通财经 · 03-30
海普瑞(09989)发布年度业绩 股东应占溢利3.49亿元 同比减少45.96%
股市必读：海普瑞（002399）3月23日收盘跌6.09%，主力净流入138.86万元
证券之星 · 03-24
股市必读：海普瑞（002399）3月23日收盘跌6.09%，主力净流入138.86万元
海普瑞遭洪泽君增持121.8万股 每股作价约5.51港元
新浪港股 · 02-04
海普瑞遭洪泽君增持121.8万股 每股作价约5.51港元
加载更多
公司概况
公司名称：
深圳市海普瑞药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2010-05-06
主营业务：
深圳市海普瑞药业集团股份有限公司的主营业务是肝素产业链，生物大分子CDMO和创新药物的投资，开发及商业化。公司的主要产品是依诺肝素钠制剂、肝素钠和依诺肝素钠原料药、分子药物CDMO服务。
发行价格：
148.00
{"stockData":{"symbol":"002399","market":"SZ","secType":"STK","nameCN":"海普瑞","latestPrice":9.53,"timestamp":1785222180000,"preClose":9.54,"halted":0,"volume":2958220,"delay":0,"changeRate":-0.001,"floatShares":1247000000,"shares":1467000000,"eps":0.2593,"marketStatus":"已收盘","change":-0.01,"latestTime":"07-28 15:00:00","open":9.5,"high":9.67,"low":9.49,"amount":28299100,"amplitude":0.0189,"askPrice":9.55,"askSize":37,"bidPrice":9.53,"bidSize":130,"shortable":0,"etf":0,"ttmEps":0.2593,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785288600000},"marketStatusCode":5,"adr":0,"adjPreClose":9.54,"symbolType":"stock","openAndCloseTimeList":[[1785202200000,1785209400000],[1785214800000,1785222000000]],"highLimit":10.49,"lowLimit":8.59,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1467296204,"isCdr":false,"pbRate":1.15,"roa":"--","peRate":36.752796,"roe":"1.55%","epsLYR":0.2382,"committee":0.340223,"marketValue":13983000000,"turnoverRate":0.0024,"status":1,"hkstockBrief":{"symbol":"09989","market":"HK","secType":"STK","nameCN":"海普瑞","latestPrice":4.28,"timestamp":1785226102968,"preClose":4.33,"halted":0,"volume":185500,"delay":0,"premium":"-61.21"},"floatMarketCap":11886000000},"requestUrl":"/m/hq/s/002399","defaultTab":"news","newsList":[{"id":"2648502516","title":"股东洪泽君增持海普瑞(09989)32.85万股 每股作价约3.99港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2648502516","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648502516?lang=zh_cn&edition=full","pubTime":"2026-07-02 18:59","pubTimestamp":1782989980,"startTime":"0","endTime":"0","summary":"6月30日，股东洪泽君增持海普瑞(09989)32.85万股，每股作价3.986港元，总金额约为130.94万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260702/20260702190218_76310.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260702/20260702190218_76310.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462474.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["002399","BK0188","BK0070","BK0239","09989","BK1191","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645883271","title":"海普瑞涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645883271","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645883271?lang=zh_cn&edition=full","pubTime":"2026-06-23 14:51","pubTimestamp":1782197486,"startTime":"0","endTime":"0","summary":"6月23日，海普瑞(09989.HK)涨超3%，早盘一度涨逾14%。截至发稿，涨2.6%，报3.95港元，成交额1475.14万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606233779660254.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606233779660254.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002399","BK0188","BK0070","BK0239","09989","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645916883","title":"港股异动 | 海普瑞(09989)涨超3% 近日旗下依诺肝素钠注射液在肯尼亚获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2645916883","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645916883?lang=zh_cn&edition=full","pubTime":"2026-06-23 14:40","pubTimestamp":1782196835,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，海普瑞涨超3%，早盘一度涨逾14%。消息面上，据海普瑞药业官微消息，近日，海普瑞药业宣布，集团全球制剂业务的核心承载主体、旗下全资子公司天道医药的依诺肝素钠注射液在肯尼亚获得批准。这是海普瑞旗下依诺肝素钠注射液在非洲获批的第四个国家，至此，该产品全球获批国家和地区数量增至80个。目前，海普瑞药业依托深圳市南山、坪山两大制剂生产基地，已形成年产5.5亿支依诺肝素钠注射液的世界级规模化产能。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457407.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0239","BK0188","BK4585","BK4588","BK0070","002399","09989","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638592398","title":"海普瑞(09989)将于6月18日派发末期股息每10股1.6604港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638592398","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638592398?lang=zh_cn&edition=full","pubTime":"2026-05-26 16:32","pubTimestamp":1779784346,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海普瑞(09989)发布公告，将于2026年6月18日派发截至2025年12月31日止年度的末期股息每10股1.6604港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","002399","VIG","EWH","BK1191","BK0188","09989","BK0070","BK0239","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637130308","title":"海普瑞将于7月22日派发末期股息每10股1.6604港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637130308","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637130308?lang=zh_cn&edition=full","pubTime":"2026-05-24 16:54","pubTimestamp":1779612840,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 海普瑞（09989）发布公告，将于2026年7月22日派发截至2025年12月31日止年度的末期股息每10股1.6604港元。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-05-24/doc-inhyytnk3405613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","VIG","BK1191","BK4585","EWH","002399","09989","BK0070","BK4588","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637334860","title":"海普瑞（002399）披露董事会完成换届选举及聘任高级管理人员、证券事务代表的公告，5月22日股价下跌0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637334860","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637334860?lang=zh_cn&edition=full","pubTime":"2026-05-22 22:39","pubTimestamp":1779460755,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，海普瑞报收于10.19元，较前一交易日下跌0.1%，最新总市值为149.52亿元。公告显示，公司于2026年5月22日召开2025年度股东会及第七届董事会第一次会议，完成董事会换届选举，并聘任高级管理人员及证券事务代表。同时选举产生董事会各专门委员会成员。公司聘任单宇为总经理，李坦为副总经理，陈娟为财务负责人，钱风奇为董事会秘书，张文为证券事务代表。相关人员均已取得相应资格证书，具备任职资格。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200045442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","09989","BK1191","BK0188","BK0239","002399","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637312478","title":"海普瑞(09989)将于7月22日派发末期股息每10股1.6604港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637312478","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637312478?lang=zh_cn&edition=full","pubTime":"2026-05-22 21:22","pubTimestamp":1779456151,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海普瑞(09989)发布公告，将于2026年7月22日派发截至2025年12月31日止年度的末期股息每10股1.6604港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445308.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1191","EWH","VIG","BK0188","BK4588","09989","BK0070","002399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637141213","title":"海普瑞(09989)：王建一获选为职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2637141213","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637141213?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:54","pubTimestamp":1779454461,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海普瑞(09989)发布公告，王建一先生已获选为第七届董事会职工代表董事;及张平先生于任期届满后，不再担任第六届董事会职工代表董事，均自2025年年度股东大会结束起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK1191","002399","09989","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637314472","title":"海普瑞完成换届选举：李锂当选董事长 单宇任总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2637314472","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637314472?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:39","pubTimestamp":1779453540,"startTime":"0","endTime":"0","summary":"5月22日，海普瑞（002399/09989）发布公告，公司召开2025年度股东会，审议通过了第七届董事会的选举，包括3名非独立董事和3名独立董事。新董事会成员包括非独立董事李锂（董事长）、李坦、单宇，独立董事黄鹏、易铭、浦洪，以及职工董事王建一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605223746998745.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605223746998745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0188","09989","BK1191","BK0239","002399","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632086476","title":"每周股票复盘：海普瑞（002399）Q1净利增19.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632086476","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632086476?lang=zh_cn&edition=full","pubTime":"2026-05-03 08:18","pubTimestamp":1777767495,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，海普瑞报收于10.87元，较上周的10.93元下跌0.55%。本周，海普瑞4月30日盘中最高价报11.04元。本周关注点业绩披露要点：海普瑞2026年一季报显示归母净利润1.88亿元，同比上升19.79%。业绩披露要点海普瑞2026年一季报显示，一季度公司主营收入13.31亿元，同比下降4.55%；归母净利润1.88亿元，同比上升19.79%；扣非净利润7149.39万元，同比下降62.15%；负债率28.12%，投资收益3033.14万元，财务费用1.28亿元，毛利率34.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300002052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK1191","002399","BK0070","09989","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660132","title":"海普瑞（002399）2026年一季报简析：净利润同比增长19.79%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632660132?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:41","pubTimestamp":1777588863,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期海普瑞发布2026年一季报。截至本报告期末，公司营业总收入13.31亿元，同比下降4.55%，归母净利润1.88亿元，同比上升19.79%。本报告期海普瑞三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达162.25%。去年的净利率为6.25%，算上全部成本后，公司产品或服务的附加值一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100006809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09989","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631543515","title":"海普瑞（002399）披露2026年第一季度报告，4月29日股价下跌0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631543515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631543515?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:24","pubTimestamp":1777472683,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，海普瑞报收于10.77元，较前一交易日下跌0.09%，最新总市值为158.03亿元。该股当日开盘10.82元，最高10.94元，最低10.72元，成交额达4604.83万元，换手率为0.34%。近日，深圳市海普瑞药业集团股份有限公司召开第六届董事会第二十一次会议，审议通过《2026年第一季度报告》《2026年第一季度业绩公告》（H股）及《2025年度环境、社会和管治报告》。会议应参与表决董事7人，实际参与表决7人，表决结果均为7票同意、0票反对、0票弃权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900069206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0239","BK0188","BK0070","002399","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631950795","title":"海普瑞(09989)一季度归母净利润1.88亿元 同比增长19.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631950795","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631950795?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:41","pubTimestamp":1777455711,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海普瑞(09989)发布2026年第一季度业绩，营业收入13.31亿元，同比减少4.55%;归属于上市公司股东的净利润1.88亿元，同比增长19.79%;基本每股收益0.1278元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09989","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627423356","title":"海普瑞（002399）披露2025年度业绩说明会安排，4月15日股价上涨0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627423356","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627423356?lang=zh_cn&edition=full","pubTime":"2026-04-15 22:29","pubTimestamp":1776263350,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘，海普瑞报收于11.44元，较前一交易日上涨0.88%，最新总市值为167.86亿元。该股当日开盘11.46元，最高11.55元，最低11.22元，成交额达5034.21万元，换手率为0.35%。近日，深圳市海普瑞药业集团股份有限公司发布《关于举办2025年度业绩说明会的公告》。公告显示，公司将于2026年4月20日15:00-16:30通过“价值在线”平台举行2025年度业绩说明会，以网络文字互动方式与投资者交流。说明会结束后，可通过平台查看会议内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500043242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","09989","002399","BK1191","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626264919","title":"股市必读：海普瑞（002399）4月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2626264919","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626264919?lang=zh_cn&edition=full","pubTime":"2026-04-09 01:14","pubTimestamp":1775668453,"startTime":"0","endTime":"0","summary":"截至2026年4月8日收盘，海普瑞报收于11.68元，上涨2.55%，换手率0.53%，成交量6.67万手，成交额7731.46万元。董秘最新回复投资者： 董秘你好，贵公司A股25年年报显示：原料药的全年毛利率为15.72%，25年半年报显示：原料药的毛利率为23.82%，原料药毛利率呈明显下降趋势。当日关注点来自交易信息汇总：4月8日主力资金净流入742.52万元，呈现主动买入态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900001043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","09989","BK0239","BK0188","002399","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624658540","title":"海普瑞：公司对于Kymab、君圣泰等相关投资均取得了较好的收益表现","url":"https://stock-news.laohu8.com/highlight/detail?id=2624658540","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624658540?lang=zh_cn&edition=full","pubTime":"2026-04-03 15:00","pubTimestamp":1775199644,"startTime":"0","endTime":"0","summary":"证券之星消息，海普瑞04月02日在投资者关系平台上答复投资者关心的问题。海普瑞回复：您好，公司2025年度归母净利润同比下降，主要是2024年同期存在大额一次性投资收益的正向影响，对本报告期归母净利润同比影响较大。投资收益方面，公司对于Kymab、君圣泰等相关投资均取得了较好的收益表现，未来公司将继续坚持理性分析、有效配置、前瞻规划的投资原则。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300023601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","002399","BK1191","09989","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623794773","title":"商业化与平台能力加速升级 解锁海普瑞长期增长密码","url":"https://stock-news.laohu8.com/highlight/detail?id=2623794773","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623794773?lang=zh_cn&edition=full","pubTime":"2026-03-31 10:30","pubTimestamp":1774924201,"startTime":"0","endTime":"0","summary":"业绩增长的同时，海普瑞正持续升级工业化平台能力与全球商业化能力，以期实现公司长期高质量发展。报告期内，公司核心业务肝素制剂表现增长亮眼，依诺肝素钠制剂销量实现逾两成增长，全球收入两位数增长。另外，平台能力与智能制造建设也成为海普瑞未来高质量发展的关键因素，在市场看来，医药企业的智造能力是其全球竞争力的核心载体，并决定自身质量高度、成本优势与市场边界。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/31/20260331593458.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/31/20260331593458.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260331/32115066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0070","BK0188","BK0239","BK1191","09989","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623349539","title":"海普瑞(09989)发布年度业绩 股东应占溢利3.49亿元 同比减少45.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623349539","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623349539?lang=zh_cn&edition=full","pubTime":"2026-03-30 22:24","pubTimestamp":1774880694,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海普瑞(09989)发布2025年度业绩，收入54.38亿元(人民币，下同)，同比增长3.41%;母公司拥有人应占溢利3.49亿元，同比减少45.96%;每股基本盈利0.24元，拟派末期现金股息每十股公司普通股1.45元(含税)。公告称，销售产品生产及销售的收入增加，主要由于报告期内药物制剂销量大幅增长所致。 毛利率的降低乃主要由于销售成本包含了存货跌价准备，由上年的人民币760万元增至人民币3650万元，及是受市场环境影响，原料药单价呈下行趋势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422205.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0188","09989","BK0239","002399","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621828900","title":"股市必读：海普瑞（002399）3月23日收盘跌6.09%，主力净流入138.86万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621828900","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621828900?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:33","pubTimestamp":1774297990,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，海普瑞报收于10.33元，下跌6.09%，换手率0.51%，成交量6.34万手，成交额6685.07万元。来自资金流向：3月23日主力资金净流入138.86万元，与前10个交易日主力资金累计净流出形成反差。交易信息汇总股价提醒3月23日海普瑞收盘报10.33元，跌6.09%，当日成交633.61万元。根据收盘数据统计，该股已连续3日下跌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400005092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0070","002399","BK0239","BK1191","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608812943","title":"海普瑞遭洪泽君增持121.8万股 每股作价约5.51港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608812943","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608812943?lang=zh_cn&edition=full","pubTime":"2026-02-04 08:04","pubTimestamp":1770163440,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新资料显示，2月2日，洪泽君增持海普瑞（09989）121.8万股，每股作价5.509港元，总金额约为671万港元。增持后最新持股数目为2246.95万股，最新持股比例为10.20%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-02-04/doc-inhkrayr9887953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09989","002399","BK0239","BK1191","BK0070","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785240485780,"stockEarnings":[{"period":"1week","weight":-0.0354},{"period":"1month","weight":0.1029},{"period":"3month","weight":-0.1006},{"period":"6month","weight":-0.2124},{"period":"1year","weight":-0.2797},{"period":"ytd","weight":-0.1777}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":-0.042},{"period":"3month","weight":-0.054},{"period":"6month","weight":-0.0706},{"period":"1year","weight":0.0736},{"period":"ytd","weight":-0.0279}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳市海普瑞药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2010-05-06","address":"广东省深圳市南山区松坪山郎山路21号","registeredCapital":"146729万元","survey":" 深圳市海普瑞药业集团股份有限公司的主营业务是肝素产业链，生物大分子CDMO和创新药物的投资，开发及商业化。公司的主要产品是依诺肝素钠制剂、肝素钠和依诺肝素钠原料药、分子药物CDMO服务。","listedPrice":148},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海普瑞(002399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海普瑞(002399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海普瑞,002399,海普瑞股票,海普瑞股票老虎,海普瑞股票老虎国际,海普瑞行情,海普瑞股票行情,海普瑞股价,海普瑞股市,海普瑞股票价格,海普瑞股票交易,海普瑞股票购买,海普瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海普瑞(002399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海普瑞(002399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}